Thanksgiving is a great holiday. Wait, is that too much? OK, let’s call it a really, really good annual celebration. Since its declaration as a national holiday by none other than President Abraham ...

Background: Pediatric sepsis remains a leading cause of mortality in critically ill children worldwide. Current approaches to sepsis prognosis rely on clinical criteria and biomarkers with variable ...

Amgen's bemarituzumab trial has taken a turn, with a final analysis showing weaker survival benefits than previously found in an earlier pre-specified interim analysis. In June, Amgen and China ...

Introduction: Cost-effectiveness analysis (CEA) serves as a critical tool to evaluate the economic sustainability of new treatments. However, many CEA tools are not specifically tailored to address ...

JERSEY CITY, N.J., Aug. 19, 2025 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of a retrospective analysis of patients living with amyotrophic lateral ...

Abstract: The growing integration of renewable energy sources into distribution networks leads to changes in grid operations, especially with respect to load profiles, which may influence the aging ...

Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event-free survival in patients with resectable non–small-cell lung cancer (NSCLC) in a phase 3 trial.

Outcomes of KRAS G12C inhibitors in metastatic pancreatic cancer: A systematic review and meta-analysis. The efficacy and safety of Surufatinib monotherapy as a third-line treatment for advanced ...

Institutional experience with pancreatic head versus body/tail cancer: A comparison of treatment outcomes. Preclinical study of safety and efficacy in vivo of a yttrium-90 resin microspheres glue ...

ABSTRACT: Ordinal outcome neural networks represent an innovative and robust methodology for analyzing high-dimensional health data characterized by ordinal outcomes. This study offers a comparative ...

Innovative statistical method helps determine ideal threshold times in restricted mean survival time analyses. The restricted mean survival time (RMST) analysis technique was introduced in health care ...

Akeso has shared for the first time overall survival data from a high-profile Keytruda head-to-head trial for its PD-1xVEGF bispecific ivonescimab—and investors in the company's partner Summit ...